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In this explorative study, forty-seven patients with
relapsing-remitting multiple sclerosis were randomized to
a custom 6-week cognitive rehabilitation intervention (n =
23) using the BrainHQTM web-based platform and to a
control group condition (n = 24). Cognitive rehabilita-
tion intervention consisted of two 40-minute sessions per
week. All patients were tested with the Brief International
Cognitive Assessment for Multiple Sclerosis battery, the
Stroop Color-Word Test, and the trail making test, while
the Beck Depression Inventory - Fast Screen questionnaire
was used as a measure of mood and the cognitive re-
serve index as a measure of cognitive reserve. We used
the reliable change index, to calculate clinically meaning-
ful changes of performance, and to discriminate between
responders and non-responders of this intervention. Statis-
tically significant improvement of the group receiving treat-
ment was observed mainly on measures of verbal and non-
verbal episodic memory and, to a lesser extent, on read-
ing speed, selective attention/response inhibition, and vi-
sual attention. Verbal memory and visual attention im-
provements remained significant after considering the cor-
rected for multiple comparisons level of significance. Ac-
cording to reliable change index scores, 12/23 (52.2%)
of patients in the intervention group presented meaningful
improvement in at least one measure (Greek Verbal Learn-
ing Test: 26%, Brief Visuospatial Memory Test-Revised:
17.4%, Stroop-Words test: 13%). This explorative study
provides evidence that, at least in the short term, cognitive
rehabilitation may improve the cognitive performance of
multiple sclerosis patients.
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1. Introduction
A vast number of people with multiple sclerosis (PwMS)
present cognitive deficits (Langdon, 2015). Cognitive impairment
may interfere with patient's ability to cope with everyday life activ-
ities (Weber et al., 2019) and tends to progress during the disease
(Amato et al., 2001). Treatment of cognitive impairment in multi-
ple sclerosis (MS) is challenging with clinicians suggesting that a
brief assessment of cognitive functions should be implemented in
everyday clinical practice to accurately evaluate disease severity
(Bakirtzis et al., 2018; Saccà et al., 2017).
Pharmaceutical agents and supplements used in dementia have
not proven to be efficacious in MS (Amato et al., 2013; He et
al., 2013) while there is limited evidence to support that disease-
modifying drugs may have an impact on cognitive functions in
MS (Niccolai et al., 2017). It has been suggested that physical ex-
ercise may be an alternate approach since, at least in the healthy
population, there is some evidence of beneficial effects on cog-
nitive functions (Feinstein, 2011; Sandroff, 2015). Nevertheless,
the beneficial effects of physical exercise on cognition in PwMS




































































nomenon, together with the fact that intellectual enrichment may
protect from cognitive decline (Sumowski, 2015; Sumowski et al.,
2010), current research has focused on cognitive training strate-
gies.
Cognitive rehabilitation (CR) has been suggested as a poten-
tial therapeutic option for PwMS with cognitive deficits. CR is a
neurobehavioral approach aimed at improving patient cognition,
as well as assisting patients and their families in improving every-
day functionality (Sandry et al., 2016). Previous studies have sug-
gested that CR should be performed early in the disease course to
enable the reorganization of cognitive circuits (Penner et al., 2007;
Schoonheim et al., 2010). Recent work by Messinis et al. (2020)
showed that CRmight also improve cognitive functions even in the
later stages of the disease. Yet CR studies in MS failed to provide
robust evidence of efficacy and were therefore treated with skep-
ticism (Rosti-Otajärvi and Hämäläinen, 2014). Recent random-
ized clinical trials, with better methodological approaches, have
provided some evidence that at least in the short-term, CR may
improve cognitive performance in PwMS, especially on memory
(Chiaravalloti et al., 2013, 2019; Lincoln et al., 2019; Mousavi et
al., 2018). It seems that by focusing on techniques that have been
proven efficacious, a positive effect of CR in cognitive functions
may be demonstrated (McCabe et al., 2016).
The explorative studymakes use of computer programs that are
usually designed by clinical neuropsychologists who implement
various techniques or use dedicated software for computerized CR,
which contain a multitude of activities for several cognitive do-
mains (Dardiotis et al., 2018). The use of home-basedCR interven-
tions has been gaining ground in recent years (Wilms, 2020). This
approach of rehabilitation has been shown to help patients under-
stand their deficits, as it provides them with immediate feedback
on their difficulties. Furthermore, the cost is low, and patients may
perform the activities evenwhen they are located at a distance from
a rehabilitation unit (Bonavita et al., 2015). However, partial assis-
tance by a therapist may be needed so that patients understand the
purposes of the program; a therapist may guide how the program
works (De Giglio et al., 2015). Since subjects are required to per-
form activities with graduated difficulty, periodic optimization of
the related training could be performed to enhance the efficacy of
the intervention (Messinis et al., 2017). Also, patients may experi-
ence anger or disappointment because of their performance in the
program. Therefore, a therapist may help them manage these first
frustrations (Stuifbergen et al., 2011); otherwise, they may drop
out of the intervention (Shatil et al., 2010).
Information processing speed, various aspects of memory, and
to a lesser extend attention and executive functions are the cog-
nitive domains more often found impaired in PwMS (Bakirtzis et
al., 2018). Although this pattern of cognitive impairment is widely
accepted, there is no consensus yet, on how to design and perform
a CR intervention to this patient group. Therefore, we aim to eval-
uate the efficacy of a 6-week semi-assisted home-based cognitive
rehabilitation program in patients with relapsing-remitting multi-
ple sclerosis (RRMS). We focus on multiple domains frequently
found impaired in MS, and the outcome was a change of perfor-
mance on cognitive measures of participants. We design a custom
CR intervention, tailored to this patient group, that could easily
be implemented in clinical practice. This study was approved by
the Ethics Committee of the Aristotle University of Thessaloniki
(2/27. 2. 2019). It was performed in accordance with the ethical
standards of the Declaration of Helsinki and its later amendments.
2. Materials and Methods
2.1 Participants
Patients with RRMS diagnosed with the 2017 revised McDon-
ald criteria (Thompson et al., 2018) were included. All participants
were recruited from the outpatient clinic and provided written in-
formed consent before their inclusion in this research. Patients
were adults diagnosed with RRMS, clinically and radiologically
stable for at least 3 months before the inclusion, who performed
1.5 Standard Deviation (SD) units below average on at least one of
the neuropsychological measures administered and were not di-
agnosed with a psychiatric condition. Normative scores used in
this explorative study derived from tests' original manuals (Sym-
bol Digit Modalities Test, SDMT; Smith (1982), Brief Visuospa-
tial Memory Test-Revised, BVMT-R; Benedict (1997), or norma-
tive studies for the Greek population (Greek Verbal Learning Test,
GVLT; (Vlachou et al., 2013), Trail Making Test parts A and B,
TMT-A, TMT-B; Kosmidis et al. (2006); Zalonis et al. (2008),
Stroop Color-Word Test). Patients were randomized into the inter-
vention group (n = 23) and the control group (n = 24) by an auto-
mated randomization software. Participants' demographic, disease
characteristics, and baseline performances on testing are presented
in Table 1.
2.2 Evaluations
A neurological examination was performed by a certified Ex-
panded Disability Status Scale (EDSS; Kurtzke (1983)) rater.
Neuropsychological assessment was performed by an experienced
neuropsychologist who was blinded to the patient's group alloca-
tion and was carried out in a quiet room with no distractions at
the neuropsychology laboratory of the clinic. The assessment in-
cluded the Greek adaptation of the brief international cognitive
assessment for multiple sclerosis (BICAMS) battery (Polychroni-
adou et al., 2016). This battery includes the GVLT (Vlachou et al.,
2013) as a measure of verbal episodic memory, BVMT-R (Bene-
dict, 1997) as a measure of visuospatial memory and the oral ver-
sion of the SDMT (Smith, 1982) as a measure of information pro-
cessing speed. Furthermore, trail making test (see, e.g., Zalonis et
al. (2008)) was used to evaluate visual attention (TMT-A) as well
as divided attention, set-shifting (task switching) and cognitive
flexibility (TMT-B; see, e.g., Lezak et al. (2012)). Stroop Color-
Word Test (see, e.g., Golden (1978); Kosmidis et al. (2006)) was
used to evaluate reading speed (Color test), selective attention, and
response inhibition (Color-Word test, Lezak et al. (2012)). Both
groups were re-examined within 5 days from the end of training
with alternate forms of the tests, where available (SDMT; Smith
(1982), BVMT-R; Benedict (1997), GVLT; Vlachou et al. (2013)).
Also, in the baseline assessment, the Beck depression inventory
fast screen (Beck et al., 2003) was administered as a measure
of mood. The cognitive reserve index (CRI) (see Maiovis et al.
(2016)) was used to quantify the cognitive reserve of patients based
on their level of education, vocational status, and leisure activities.
2.3 Intervention
The 6-week CR intervention was performed using the web-
based BrainHQTM platform (BrainHQ, Posit Sciences, https:
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Table 1. Baseline Demographical and Clinical Data of participants.
Intervention Group (N = 23) Control Group (N = 24) P-value1
Age (years) 33.5 (16) 37.8 (19) 0.183
Females 20 (87) 20 (83.3) 1
Duration since diagnosis (years) 8.3 (10.3) 10 (8.5) 0.675
Duration since onset (years) 9.9 (10.5) 12.5 (6.8) 0.39
EDSS 2.9 (1.5) 3.5 (2.5) 0.064
SDMT 49.1 (19) 46.1 (13) 0.388
GVLT 54.2 (26) 56.5 (14) 0.93
BVMT-R 22.6 (14) 22.8 (11) 0.717
TMT-A 51.5 (23) 46.5 (22) 0.907
TMT-B 105.9 (62) 100.8 (54) 0.898
STROOP COLOR 58.7 (27) 56.9 (19) 0.662
STROOP COLOR-WORD 38 (13) 36.7 (8) 0.482
CRI 95 (7) 98.7 (10) 0.064
BDI-FS 4.5 (6) 3.8 (5) 0.379
BDI-FS: Beck Depression Inventory-Fast Screen
Values represent mean values interquartile ranges and frequencies N (%)
1Mann-Whitney U tests for numerical characteristics and Fisher's exact test for gender
//www.brainhq.com). BrainHQTM has been successfully used
in various populations such as patients with schizophrenia (Fisher
et al., 2014; Surti et al., 2011), healthy older adults (Smith et al.,
2009) and patients with MS (Charvet et al., 2017) amongst others.
BrainHQTM enables clinicians to design a custom-made CR pro-
gram using a variety of training modules. The superiority of the
training tests included in this platform over other cognitive exer-
cises has been previously demonstrated (Tennstedt and Unverzagt,
2013). We used this platform since it enables clinicians to deter-
mine the participants' level of engagement (Harvey et al., 2019) and
allows remote cognitive training. For this explorative study, par-
ticipants in the intervention group were trained on episodic mem-
ory (Memory Grid, Rhythm Recall, and To-Do List Training mod-
ules), attention (Divided Attention, Double Decision, Mixed Sig-
nals, and Freeze Frame modules) and processing speed (Eye for
Detail, Hawk-Eye, Visual Sweeps and Sound Sweeps modules).
CR was home-based and was performed in the patients' native
language. Participants were asked to enter the platform twice a
week. Patients were trained individually for the use of the plat-
form by a neuropsychologist. The activities were set in advance
and were given to patients in printed form (a complete list of the
activities is listed in Table S1). Each day of practice, patients had
to work on two scheduled activities, dedicating 20 minutes to each
one. A trained neuropsychologist got in contact with the partici-
pants weekly and assisted them in CR when needed. Also, sched-
uled visits were performed every 2 weeks, to review and optimize
the levels of difficulty in each activity, according to patients' per-
formance.
2.4 Statistical analysis
Baseline demographical and outcome data were presented
as means and interquartile ranges and frequencies. Between-
group differences were calculated with the non-parametric Mann-
Whitney U test due to the small study sample. All within-group
differences were computed by using the Wilcoxon test. The ef-
fect sizes (r) for the outcome score changes within the intervention
group were assessed by the following formula: r = Z/
√
N, where
r is the effect size (i.e., < 0.3 small, 0.3-0.5 moderate and > 0.5
large effect size), Z is the score of eachMann-WhitneyU test andN
is the study sample. To ascertain meaningful changes of outcomes,
the Reliable Change Index (RCI) was computed for each partici-
pant as previously described (Jacobson and Truax, 1991; Temkin et
al., 1999), after controlling for the practice effect by subtracting the
difference of mean scores in the control group from the individual
score differences in the intervention group. An RCI higher than
1.65, or lower than -1.65, based on the directionality of improve-
ment for each outcome, allowed us to ascertain responders and
non-responders for this specific outcome. The role of hours spent
in the system and the levels reached in the BrainHQTM web-based
platform were compared between responders and non-responders
with theMann-Whitney U test. The level of significance was set at
0.05. The Bonferroni corrected for multiple comparisons level of
significance was 0.007. The data were analyzed with SPSS v22.0
for Windows (Armonk, NY: IBM Corp).
3. Results
The sample consisted of 23 MS patients (mean age 33.5 years
old, 87% females) in the intervention group, and 24 patients (mean
age 37.8, 83.3% females) in the control group. There were no
dropouts. The two groups were not significantly different with
respect to disease duration and disability. Also, there were no sig-
nificant group differences at baseline with respect to neuropsycho-
logical assessments and the putative confounders of the cognitive
reserve as measured by the CRI (P = 0.064) and depressive symp-
toms as measured by the BDI-FS (P = 0.379; Table 1).
Within-group comparisons revealed significant improvements
in verbal learning (GVLT, P < 0.001), visuospatial memory
(BVMT-R, P = 0.001), visual attention (TMT-A, P < 0.001), task
switching (TMT-B, P < 0.001), reading speed and response in-
hibition (Stroop tests, P = 0.002) within the intervention group.
Surprisingly, a significant improvement in task switching (TMT-
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Table 2. Within Group Changes for Study Outcomes.
Intervention Group (N = 23)
Before After P-value1
SDMT 49.1 (19) 50 (12) 0.251
GVLT 54.2 (26) 63.7 (17) < 0.001**
BVMT-R 22.6 (14) 27.5 (10) 0.001**
TMT-A 51.5 (23) 38.2 (20) < 0.001**
TMT-B 105.9 (62) 73.4 (27) < 0.001**
STROOP COLOR 58.7 (27) 65.2 (18) 0.002**
STROOP COLOR-WORD 38 (13) 44 (16) 0.002**
Control Group (N = 24)
Before After P-value1
SDMT 46.1 (13) 44.5 (13) 0.135
GVLT 56.5 (14) 54.4 (14) 0.13
BVMT-R 22.8 (11) 22.5 (9) 0.867
TMT-A 46.5 (22) 43.4 (21) 0.485
TMT-B 100.8 (54) 82.5 (24) 0.006**
STROOP COLOR 56.9 (19) 57.5 (23) 0.518
STROOP COLOR-WORD 36.7 (8) 38.8 (9) 0.213
Values represent mean raw scores (interquartile ranges) and frequencies N (%)
1Wilcoxon signed-rank test
∗P ≤ 0.05, ∗∗ PC ≤ 0.007 (Bonferroni corrected level of significance)
Table 3. Between Group Comparisons for Outcome Changes and Effect Sizes.
Intervention Group (N = 23) Control Group (N = 24) P-value1 Effect Size
SDMT 1.8 (-10, 14) 1.7 (-14, 16) 0.073 0.26
GVLT 9 (-6, 24) -2.2 (-19, 15) < 0.001** 0.6
BVMT-R 5 (-6, 15) -0.3 (-13, 12) 0.01* 0.38
TMT-A -13.3 (-131, 0) -2.6 (-45, 22) 0.005** 0.15
TMT-B -30.6 (-114, 11) -18.3 (-79, 17) 0.099 0.24
STROOP COLOR 6.5 (-8, 26) 0.6 (-33, 27) 0.038* 0.3
STROOP COLOR-WORD 6.1 (-21, 24) 2 (-16, 30) 0.03* 0.32
Values represent mean raw scores across follow-up (minimum, maximum)
1Mann-Whitney U tests
∗P ≤ 0.05,∗∗PC ≤ 0.007 (Bonferroni corrected level of significance)
B, P = 0.006) was noted in the control group (Table 2). When
group comparisons were tested by considering individual score
changes across follow-up, significantly beneficial effect sizes of
the intervention were noted for verbal learning (GVLT, large effect
size), visuospatial memory (BVMT-R, moderate effect size), read-
ing speed and response inhibition (Stroop tests, moderate effect
size) and visual attention (TMT-A, small effect size; Table 3). Ver-
bal learning and visual attention remained significant after consid-
ering the Bonferroni corrected P-value of significance.
More importantly, based on the RCI scores, a total of 12
(52.2%) out of the 23 patients in the intervention group showed
meaningful improvement in at least one outcome (Table 4). There
were no responders in the control group. Among responders, three
patients improved in three tests, two in two tests and seven in
one test. Most responders showed improvements in verbal mem-
ory (GVLT, 26%), followed by visuospatial memory (BVMT-R,
17.4%) and response inhibition (13% for Stroop Color-Word test),
which is consistent with the observed effect sizes. About half of
the participants (12/23, 52.1%) were compliant with the study pro-
tocol. Responders spent more time in the intervention sessions
than non-responders (mean± IQR: 4.3± 5.7 vs. 2.3± 2.2 hours),
but the difference was not significant (P = 0.412) (Table 5). How-
ever, responders reached a significantly higher level of memory
than non-responders (mean ± IQR: 36.6 ± 65 vs. 12 ± 11, P =
0.016), which further substantiates the beneficial effect of the in-
tervention for the memory function (Table 5).
Finally, there were no significant differences between respon-
ders and non-responders with respect to age (P = 0.608), sex (P =
0.59), disease duration since diagnosis (P = 0.748) or onset (P =
0.652), EDSS (P = 0.76), and baseline SDMT (P = 0.347), GVLT
(P = 0.217), BVMT-R (P = 0.069), TMT-A (P = 0.525), TMT-B
(P = 0.976), Stroop Color (P = 0.695), Stroop Color-Word (P =
0.449), CRI (P = 0.088) and BDI-FS (P = 0.288).
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Table 4. Reliable Change Index Values and Number of Responders to the Intervention for each Study Outcome.
Mean RCI (IQR) for Intervention Responders
SDMT -0.14 (1.11) 2 (8.7)
GVLT 0.99 (0.95) 6 (26%)
BVMT-R 0.77 (0.92) 4 (17.4)
TMT-A -0.24 (0.52) 1 (4.3)
TMT-B -0.41 (1.15) 2 (8.7)
STROOP COLOR 0.7 (0.92) 2 (8.7)
STROOP COLOR-WORD 0.38 (0.99) 3 (13)
IQR: Interquartile Range
Table 5. Hours of exercise and levels reached among responders and non-responders.
Responders (N = 12) Non-Responders (N = 11) P-value1
Hours of exercise 4.3 (5.7) 2.3 (2.2) 0.412
Levels Attention 59.6 (89) 28 (32) 0.151
Levels Memory 36.6 (65) 12 (11) 0.016*
Levels Processing Speed 23.8 (25) 23.6 (44) 0.976
Levels total 119.5 (54) 63 (63) 0.211
Values represent means (interquartile range)
1Mann-Whitney U exact test
∗P ≤ 0.05
4. Discussion
Cognitive rehabilitation with the BrainHQTM web-based plat-
form may improve cognitive functions, especially episodic mem-
ory. More specifically, there was a statistically significant
improvement in patients' performance in the GVLT, BVMT-R,
Stroop, and Trail Making Test tests, with GVLT and Trail Making
Test-A remaining significant after considering the Bonferroni cor-
rected level of significance in the study group comparisons. Their
improvement in these measures may be attributed to the fact that
through the program and their training in attention and memory
tests, they learned how they could pay more attention to stimuli
so that they can remember them (Temkin et al., 1999). Among
the tests mentioned above, the improvement of performance was
greater on the memory tests of the BICAMS battery. No statisti-
cally significant difference was observed on information process-
ing speed as measured by the SDMT, although many exercises had
focused on this cognitive domain. Research in healthy older adults
using the Double Decision module has previously demonstrated
a positive effect in processing speed (Tennstedt and Unverzagt,
2013). Whether this type of CR intervention may improve the in-
formation processing speed of PwMS or not, remains to be further
explored, perhaps with the combined use of advanced neuroimag-
ing techniques.
This home-based CR allowed participants to train in those
hours and days that were more convenient for each participant.
The type of CR activities was preselected by a neuropsychologist
based on the cognitive deficits of the studied group observed on
baseline assessment. Several cognitive rehabilitation studies have
highlighted the importance of distance learning outcomes while
showing that cognitive deficits can be improved when the pro-
gram used has specific activities and objectives, in contrast to non-
specific programs available on the internet (Charvet et al., 2017;
Chiaravalloti et al., 2013).
The improvement of cognitive performance was greater in
those who complied with the program as compared to those who
did the activities but missed several of the sessions. Only 12/23
(52.1%) were consistent with the cognitive rehabilitation program
despite the assistance provided by the neuropsychologist. Poor
adherence is common, especially in-home based CR (Dardiotis et
al., 2018); patients may not actively participate because they get
frustrated by poor performance in a project and cannot manage it
(McCabe et al., 2016; Stuifbergen et al., 2011). Also, during the
weekly contacts, participants often reported poor adherence due to
cognitive fatigue, a measure of which was not included in this ex-
plorative study and, therefore, was not quantified. Regarding the
control group's performance, an improvement was only observed
in the Trail Making Test Part B, probably due to their familiarity
with the tests and the instructions of administration (Buck et al.,
2008; Goldberg et al., 2015).
Previous studies have demonstrated that the positive effects of
CR may be transient, and patients' cognitive function often returns
to a previous state (Mousavi et al., 2018). This phenomenon could
be attributed to the lack of modification of relevant cognitive cir-
cuits (Filippi et al., 2012). It is still questionable whether brain/
cognitive training reflects an improvement in the performance in
everyday cognitive activities (McCabe et al., 2016). Nevertheless,
regarding MS, when memory training is focused on skills needed
in everyday life, such as cooking and financial management, ben-
eficial outcomes may be observed (Goverover et al., 2008). Al-
though practice effects are a crucial issue in serial neuropsycho-
logical examinations (Calamia et al., 2012), we tried to overcome
this by using alternate forms when available. Our results support
the beneficial effects of CR on the cognitive function of MS pa-
tients.
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